WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

2.05.26

Wilson Sonsini Advises ElevenLabs on $500 Million Series D
On February 4, 2026, ElevenLabs announced that it has raised $500 million in a Series D financing round led by Sequoia Capital. Andreessen Horowitz and ICONIQ also participated in the investment along with new investors Lightspeed Venture Partners, Evantic Capital, and BOND. Wilson Sonsini Goodrich & Rosati advised ElevenLabs on the transaction.
Client Highlights

8.20.25

Wilson Sonsini Advises 1Kosmos on $57 Million Series B
On August 12, 2025, 1Kosmos, a leader in identity proofing and passwordless authentication, announced a $57 million Series B funding round, including a $10 million line of credit from Bridge Bank. The round was led by Forgepoint Capital and Origami’s Oquirrh Ventures with participation by Craig Abod, Founder and President of Carahsoft, NextEra Energy Ventures, Gula Tech Adventures, and the 1Kosmos management team. Wilson Sonsini Goodrich & Rosati advised 1Kosmos on the transaction.
Client Highlights

8.15.25

Wilson Sonsini Advises Qloud Games on $5 Million Seed Round
On August 13, 2025, Sydney, Australia-based Qloud Games, the independent studio behind the upcoming massively multiplayer online (MMO) game Loftia, announced a $5 million seed funding round led by BITKRAFT Ventures and GFR Fund, with participation from a16z Speedrun, 1UP Fund, and Gaingels. Wilson Sonsini Goodrich & Rosati advised Qloud Games on the transaction.

Founded by Michael Su, Martina Qin, and Eric Mallon, Qloud Games is pioneering the first cozy MMO set in a vibrant solarpunk world. Unlike traditional MMOs or life-sim games, Loftia is designed from the ground up to foster positive, collaborative, and eco-conscious gameplay.

The Wilson Sonsini team that advised Qloud Games on the transaction included Jonathan Chan, Mark Baudler, Angela Loc, and Laura Odujinrin.

For more information, please see Qloud Games’ news release. Additional coverage is available on GamesBeat.
Client Highlights

1.30.25

Wilson Sonsini Advises ElevenLabs on $180 Million Series C Funding
On January 30, 2025, ElevenLabs announced that it has raised $180 million in a Series C funding round to make speech the new standard for digital interaction. The round was co-led by a16z and ICONIQ Growth, with additional new investors NEA, World Innovation Lab (WiL), Valor, Endeavor Catalyst Fund, and Lunate. Existing investors Sequoia Capital, Salesforce Ventures, Smash Capital, SV Angel, NFDG, and BroadLight Capital are also increasing their support. The company is further partnering with strategic investors, including Deutsche Telekom, LG Technology Ventures, HubSpot Ventures, NTT DOCOMO Ventures, and RingCentral Ventures. Wilson Sonsini Goodrich & Rosati advised ElevenLabs on the Series C transaction.
Client Highlights

1.08.25

Wilson Sonsini Advises Transcarent on Acquisition of Accolade and Preferred Stock Financing Led by General Catalyst
On January 8, 2025, Transcarent, the “One Place for Health and Care,” and Accolade, a leader in health advocacy, expert medical opinions, and primary care, announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total equity value of approximately $621 million. Transcarent will finance the transaction through a fully committed equity financing led by General Catalyst and Glen Tullman’s 62 Ventures. Wilson Sonsini Goodrich & Rosati is advising Transcarent on both the acquisition and the financing.
Client Highlights

9.19.24

Wilson Sonsini Advises Pie on $11.5 Million Series A
On September 18, 2024, in a Wall Street Journal exclusive, Pie, a mobile events app, revealed that it has raised $11.5 million in a Series A financing round, led by Forerunner Ventures and included participation from Ev Williams (a co-founder of Twitter and founder of Medium), Origin Ventures, and Renegade Partners, as well as longtime investor Precursor Ventures. The company has raised $24 million to date.
Client Highlights

5.09.24

Wilson Sonsini Advises Lagrange Labs on $13.2 Million Seed Round
On May 8, 2024, Lagrange Labs announced a $13.2 million Seed Round, led by Founders Fund, with participation from Archetype Ventures, 1kx, Maven11, Fenbushi Capital, Volt Capital, CMT Digital, and Mantle Ecosystem Fund, in addition to various friends, supporters, partners, and angels. Lagrange Labs is the creator and distributor of a new Zero-Knowledge Coprocessing protocol that enables verifiable computations at big data scale across various blockchains. Its unique ZK Coprocessing approach involves a decentralized network of nodes that execute computations off-chain and generate ZK proofs of the results to submit on-chain, in a hyper-parallel manner, thereby unlocking significant efficiency and cost gains. By providing hyper-scalable proving, Lagrange opens the door for innovations in cross-chain interoperability and applications requiring complex computations over big data. 
Client Highlights

5.06.24

Wilson Sonsini Advises Transcarent on $126 Million Series D
On May 2, 2024, health tech company Transcarent announced a $126 million Series D funding round led by General Catalyst and 7wireVentures, with participation from investors Geodesic Capital, Memorial Hermann Health System, Threshold Ventures, Kinnevik, Ally Bridge Group, Human Capital, Merck Global Health Innovation Fund, Alta Partners, and Leaps by Bayer. This latest investment brings total funding raised to approximately $450 million from a diverse group of investors at a valuation of $2.2 billion. Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction.
Client Highlights

1.26.24

Wilson Sonsini Advises ElevenLabs on $80 Million Series B Financing
On January 22, 2024, ElevenLabs, a voice technology research company, announced an $80 million Series B financing round co-led by Andreessen Horowitz, Nat Friedman, Daniel Gross, with participation from Sequoia Capital, SV Angel, Smash Capital, BroadLight Capital, and Credo Ventures. Wilson Sonsini Goodrich & Rosati advised ElevenLabs on the transaction.
Client Highlights

3.07.23

Wilson Sonsini Advises Transcarent in Proposed Acquisition of 98point6 AI-Powered Virtual Care Platform, Care Business
On March 6, 2023, Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care, announced plans to acquire an AI-powered virtual care platform and on-demand primary care business from 98point6. The acquisition will give Transcarent access to 98point6’s technology and an affiliated medical group of providers skilled at delivering high-quality, on-demand care.
Client Highlights

2.21.23

Firm Advises Regie.ai on $20.8 Million Series A investment
On February 9, 2023, Regie, the generative AI software-as-a-service (SaaS) platform, announced that it has closed its $20.8 million Series A round with investments from Khosla Ventures, Scale Venture Partners, Foundation Capital and others. Wilson Sonsini Goodrich & Rosati represented Regie.ai on the Series A transaction.
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.